Santa Monica
Sherry’s clients include banks, mortgage originators and servicers, mortgage brokers, commercial lenders, bank holding companies, private equity firms, investment advisors, investment managers, finance companies, fintechs, consumer reporting agencies, data brokers, debt collection companies and related service providers.
She is a Certified Information Privacy Professional (CIPP/US), and was a member of the Mortgage Bankers Association’s 2016 class of Future Leaders and the California Mortgage Bankers Association’s 2014 class of Future Leaders.
Prior to joining Orrick, Sherry was a partner at Buckley LLP. She has been an associate in private practice. She also clerked for the Honorable Jeanette J. Clark in the Superior Court of the District of Columbia.
Washington, D.C.
Jerry is a thought leader in the field of financial services regulation. He co-hosts RegFi, a weekly podcast series, that explores how financial regulation will change more in the next 10 years than in the last 50: https://www.orrick.com/en/Podcasts/RegFi.
Early in his career, Jerry served as Minority Staff Director of the United States Senate Banking Committee, and he played an important role in drafting many of the laws that impact the consumer financial services industry today. Since entering private practice, he has guided clients in developing compliance programs, dealing with regulatory and enforcement challenges and helping shape public policy.
Throughout his career, he has focused on promoting enhanced delivery of financial services. He was a leader in advocating the passage of the federal ESign Act, which authorized use of electronic records in financial services and other transactions. He served as counsel to the Drafting Committee for Standards and Procedures for Electronic Records and Signatures (SPeRS). He co-authored The Law of Electronic Records and Signatures (West Publishing Company) as well as Introduction to Mortgage Banking (American Bankers Association).
He has also taken a lead in promoting national data protection standards. His American Banker article, “Congress needs to hurry up on data protection,” lays out the case for national standards as an alternative to a patchwork of state privacy laws. He serves as advisor to the Financial Services Trade Associations Data Protection Working Group, an informal alliance of national financial trade associations responding to fast changing legislative and regulatory developments related to privacy and data security. He is also an advisor to the Association for Data and Cyber Governance (ADCG) and the Alliance for Innovation in Regulation (AIR).
His clients include banks, mortgage companies, credit card issuers, insurance companies, broker dealers, fintech companies, investment banks and private equity investors. Jerry provides strategic counsel and advice on business formations and acquisitions, licensing and chartering, risk management and enforcement matters involving federal and state regulators.
He has defended companies that are targets of inquiries or enforcement actions by the Office of the Comptroller of the Currency (OCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve, Consumer Financial Protection Bureau (CFPB), Federal Trade Commission (FTC), Department of Housing and Urban Development (HUD), Congressional Committees and state attorneys general.
Jerry has promoted a modernized approach to financial regulation (regtech). He led Buckley LLP's effort to publish a widely read white paper titled “Financial Regulators’ Dilemma: Administrative and Regulatory Hurdles to Innovation.” The paper is based on interviews with Heads of Innovation at the principle financial agency regulators, and lays out legal and administrative stumbling blocks identified by regulators themselves impeding regtech advances.
Jerry's opinion pieces regularly appear in financial service publications. He has advocated for development of “dynamic disclosures” to offer more useful information to consumers than is provided under the often cumbersome and voluminous static disclosures currently provided.
An article he wrote in the American Banker in 2016, “The Compliance Officer Bill of Rights,” focused attention on the growing risks faced by compliance officers. This led to a symposium on “Rights and Responsibilities of Today’s Chief Compliance Officers — Their Evolving Role,” which was chaired by Jerry and sponsored by American University Washington College of Law. Chief compliance officers from the nation’s leading companies participated in this seminal discussion about how to define and make safe the job of a chief compliance officer.
He has acted as counsel for a number of national financial services trade associations on matters before regulatory agencies and Congress, and in filing amicus briefs related to the interpretation of banking and consumer finance laws in cases before the U.S. Supreme Court and appellate courts.
He is an Adjunct Associate Professor of Law at American University's Washington College of Law. In 2007, he founded a national financial services consulting company known as Treliant Risk Advisors.
In 2015 he was awarded the Senator William Proxmire Lifetime Achievement Award from the American College of Consumer Financial Services Lawyers.
Silicon Valley
Michael applies his broad experience in venture capital financings, public offerings, mergers and acquisitions, strategic alliances, technology licensing, and corporate spin-out transactions to each engagement. He has undertaken over 300 venture capital financings raising an estimated $7 billion for his clients, recently assisting Auris Health to raise over $650 million in financings before its sale to J&J for up to $5.75 billion.
He also brings extensive experience negotiating strategic alliances, representing clients in significant collaborations with GSK, Amgen, Schering-Plough, J&J, Daiichi, Astellas, King Pharmaceuticals, and most recently Pfizer, Merck, Baxter and Dainippon Sumitomo Pharma Co., Ltd.
Michael was the lead lawyer on the initial public offerings for Illumina, Neurocrine Biosciences, Cytokinetics, Pain Therapeutics, NeurogesX, Sequana Therapeutics, Ciphergen Biosystems, Argonaut Technologies, and Microcide Pharmaceuticals.
Michael was also the lead lawyer responsible for negotiating many notable biopharmaceutical spin-outs, including Onyx Pharmaceuticals (Chiron-Cetus), Tularik (Genentech), X-Ceptor (Ligand Pharmaceuticals), Metabasis (Gensia Sicor), and as well on the reverse merger of Transcept Pharmaceuticals with Novacea, creating a new publicly traded entity.
New York
Alyssa navigates clients through privacy programs and policy creation, and provides guidance on compliance with federal, state and international laws and regulations, including the U.S. state privacy laws in California, Colorado, Connecticut, Utah, Virginia and other states, the General Data Protection Regulation (GDPR), the Federal Trade Commission Act (FTC Act), the Health Insurance Portability and Accountability Act (HIPAA) and state data breach notification laws. She advises clients on security incident response and federal and state investigations related to privacy and data security. She also provides assessments of privacy and security practices for companies carrying out due diligence in the context of corporate transactions.
Austin
Ana's practice focuses on public finance, which includes representing local governments, school districts, and financial institutions that underwrite bonds. She represents her clients in a range of public finance matters, such as general obligation and revenue bonds and public improvement districts.
Seattle
Jason is a member of Orrick's technology companies practice group. He works with both early-stage and late-stage companies and assists with all aspects of formation and venture capital financing. He provides advice to companies seeking exit transactions such as mergers & acquisitions, initial public offerings, or SPAC transactions. Jason also advises investors planning to invest in tech companies in various industries and markets.
Prior to joining Orrick, Jason served in the U.S. Army as an Infantry officer and as a Military Intelligence officer.